CANbridge Pharmaceuticals Inc. (HKG:1228)
Hong Kong
· Delayed Price · Currency is HKD 2.600
+0.110 (4.42%)
At close: Mar 10, 2026
CANbridge Pharmaceuticals Market Cap
CANbridge Pharmaceuticals has a market cap or net worth of 1.27 billion as of March 10, 2026. Its market cap has increased by 2,136.18% in one year.
Market Cap
1.27B
Enterprise Value
1.31B
Revenue
68.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
2.60
Market Cap Chart
Since December 10, 2021, CANbridge Pharmaceuticals's market cap has decreased from 3.78B to 1.27B, a decrease of -66.28%. That is a compound annual growth rate of -22.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 10, 2026 | 1.33B | 1.59% |
| Dec 31, 2025 | 1.31B | 2,215.73% |
| Dec 31, 2024 | 56.50M | -86.56% |
| Dec 29, 2023 | 420.31M | -59.56% |
| Dec 30, 2022 | 1.04B | -72.41% |
| Dec 31, 2021 | 3.77B | -0.22% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HighTide Therapeutics | 1.37B |
| Beijing Biostar Pharmaceuticals | 1.37B |
| Kintor Pharmaceutical | 1.44B |
| Immunotech Biopharm | 1.45B |
| Shanghai Bio-heart Biological Technology | 1.20B |
| Mabpharm | 1.69B |
| Cutia Therapeutics | 1.71B |
| Wuhan YZY Biopharma | 1.10B |